Bendamustine Chemical Properties

Boiling point:

585.2±50.0 °C(Predicted)

Density 

1.31±0.1 g/cm3(Predicted)

storage temp. 

-20°C, protect from light

solubility 

DMSO : 100 mg/mL (279.13 mM; Need ultrasonic)

pka

4.50±0.10(Predicted)

Safety Information

Hazardous Substances Data

16506-27-7(Hazardous Substances Data)

Bendamustine Usage And Synthesis

Uses

Treatment of hematologic cancer, especially non-Hodgkin’s lymphoma.

Definition

ChEBI: Bendamustine is a member of benzimidazoles.

brand name

Ribomustine (Amcis AG, Switzerland).

Enzyme inhibitor

This nitrogen mustard and anticancer drug (FWfree-acid = 358.26 g/mol; CAS 16506-27-7), also known by its code name SDX-105, its trade names Treanda?, Treakisym?, Ribomustin?, and Levact?, as well as by its systematic name 4-[5-[bis(2-chloroethyl)amino]-1-methylbenzimidazol-2- yl]butanoic acid, is a relatively nonspecific DNA alkylating agent that causes intra- and inter-strand cross-links. Bendamustine is used in the treatment of chronic lymphocytic leukemia (CLL), Hodgkin’s disease, nonHodgkin’s lymphoma, multiple myeloma and lung cancer. Pharmacokinetics: After intravenous infusion, >95% of the drug becomes protein-bound, mainly to albumin; however, only free bendamustine is active. Bendamustine is metabolized by liver cytochrome p450, and elimination (renal) is biphasic, with an initial half-life of 6–10 minutes and a terminal half-life of approximately 30 minutes.

Bendamustine(16506-27-7)Related Product Information

• Benzyldimethylcarbinyl butyrate
• Chlorambucil
• 6-Aminocaproic acid
• Glycine
• Carmustine
• Kresoxim-methyl
• Bendamustine hydrochloride
• Lomustine
• Mechlorethamine hydrochloride
• 2-(2-Aminoethylamino)ethanol
• Benzimidazole
• Tris(hydroxymethyl)aminomethane
• Methyl salicylate
• Bensulfuron methyl
• 4-Aminobutyric acid
• Thiophanate-methyl
• Methyl
• 2-Butanone